Zevtera ceftobiprole medocaril regulatory update

Basilea said Switzerland approved Zevtera ceftobiprole medocaril to treat community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP), in ...